FI941377A0 - Neuroleptiska 2-substituerade perhydro-1-H-pyrido/1,2-a/pyraziner - Google Patents

Neuroleptiska 2-substituerade perhydro-1-H-pyrido/1,2-a/pyraziner

Info

Publication number
FI941377A0
FI941377A0 FI941377A FI941377A FI941377A0 FI 941377 A0 FI941377 A0 FI 941377A0 FI 941377 A FI941377 A FI 941377A FI 941377 A FI941377 A FI 941377A FI 941377 A0 FI941377 A0 FI 941377A0
Authority
FI
Finland
Prior art keywords
pct
pyrazines
neuroleptic
pyrido
substituted perhydro
Prior art date
Application number
FI941377A
Other languages
English (en)
Finnish (fi)
Other versions
FI941377A (sv
Inventor
Gene Michael Bright
Kishor Amratlal Desai
Thomas Francis Seeger
Teresa Annette Smolarek
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI941377A publication Critical patent/FI941377A/sv
Publication of FI941377A0 publication Critical patent/FI941377A0/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
FI941377A 1991-09-25 1994-03-24 Neuroleptiska 2-substituerade perhydro-1-H-pyrido/1,2-a/pyraziner FI941377A0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76533291A 1991-09-25 1991-09-25
PCT/US1992/006625 WO1993006101A1 (en) 1991-09-25 1992-08-14 NEUROLEPTIC 2-SUBSTITUTED PERHYDRO-1-H-PYRIDO[1,2a]PYRAZINES

Publications (2)

Publication Number Publication Date
FI941377A FI941377A (sv) 1994-03-24
FI941377A0 true FI941377A0 (sv) 1994-03-24

Family

ID=25073279

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941377A FI941377A0 (sv) 1991-09-25 1994-03-24 Neuroleptiska 2-substituerade perhydro-1-H-pyrido/1,2-a/pyraziner

Country Status (25)

Country Link
US (1) US5565453A (sv)
EP (1) EP0607163B1 (sv)
JP (1) JPH08827B2 (sv)
CN (1) CN1071167A (sv)
AT (1) ATE146178T1 (sv)
AU (1) AU655071B2 (sv)
BR (1) BR9206541A (sv)
CA (1) CA2118936A1 (sv)
CZ (1) CZ281775B6 (sv)
DE (1) DE69215886T2 (sv)
DK (1) DK0607163T3 (sv)
ES (1) ES2096099T3 (sv)
FI (1) FI941377A0 (sv)
GR (1) GR3022483T3 (sv)
HU (1) HUT71488A (sv)
IL (1) IL103204A (sv)
MX (1) MX9205385A (sv)
MY (1) MY108303A (sv)
NO (1) NO941084D0 (sv)
NZ (1) NZ244473A (sv)
PL (1) PL170889B1 (sv)
PT (1) PT100891A (sv)
TW (1) TW215090B (sv)
WO (1) WO1993006101A1 (sv)
ZA (1) ZA927306B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
WO1996010571A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO[1,2-a]PYRAZINE DERIVATIVES
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
JP3910627B2 (ja) * 2003-03-12 2007-04-25 ファイザー・プロダクツ・インク ピリジルオキシメチルおよびベンゾイソオキサゾールのアザビシクロ環の誘導体
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
CA2889249C (en) * 2012-12-20 2021-02-16 Francois Paul Bischoff Tricyclic 3,4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione derivatives as gamma secretase modulators
AU2014206834B2 (en) 2013-01-17 2017-06-22 Janssen Pharmaceutica Nv Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione

Also Published As

Publication number Publication date
PT100891A (pt) 1993-10-29
CA2118936A1 (en) 1993-04-01
NO941084L (no) 1994-03-24
IL103204A0 (en) 1993-02-21
EP0607163A1 (en) 1994-07-27
GR3022483T3 (en) 1997-05-31
AU2460992A (en) 1993-04-27
HUT71488A (en) 1995-11-28
NZ244473A (en) 1995-04-27
JPH08827B2 (ja) 1996-01-10
HU9400851D0 (en) 1994-06-28
DE69215886D1 (de) 1997-01-23
JPH06506701A (ja) 1994-07-28
NO941084D0 (no) 1994-03-24
AU655071B2 (en) 1994-12-01
ES2096099T3 (es) 1997-03-01
WO1993006101A1 (en) 1993-04-01
DE69215886T2 (de) 1997-04-03
TW215090B (sv) 1993-10-21
PL170889B1 (pl) 1997-02-28
ATE146178T1 (de) 1996-12-15
ZA927306B (en) 1994-03-24
BR9206541A (pt) 1995-04-25
MY108303A (en) 1996-09-30
CN1071167A (zh) 1993-04-21
CZ281775B6 (cs) 1997-01-15
EP0607163B1 (en) 1996-12-11
IL103204A (en) 1996-05-14
FI941377A (sv) 1994-03-24
US5565453A (en) 1996-10-15
MX9205385A (es) 1993-03-01
CZ395792A3 (en) 1994-05-18
DK0607163T3 (da) 1997-03-17

Similar Documents

Publication Publication Date Title
GB2270075B (en) Substituted 2-phenyl-3-methoxypropenoate fungicides
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
HK186596A (en) Pyridine and pyridine n-oxide derivatives of diarylmethyl-piperidines or piperazines compositions and use thereof
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
ES2164639T3 (es) Quinoxalinas, procedimiento para su preparacion y su empleo.
DE69201748D1 (de) Pyrazinderivate.
DK0607163T3 (da) Neuroleptiske 2-substituerede perhydro-1-H-pyrido- 1,2-a pyraziner
FI860073A (fi) 6,7-disubstituerade 1-cyklopropyl-1,4-dihydro-4-oxo-1,8-naftyridin-3-karboxylsyror.
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
DK0777653T3 (da) Dihydropyridinderivater som bradykininantagonister
ES2080320T3 (es) Medicamento inmunoestimulante a base de glicopeptidolipidos polares de mycobacterium chelonae.
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
DE69013413D1 (de) Geregelte Gleichstromleistungsversorgung.
EP0509098A4 (en) Ataractic
DE69215511D1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
FI990433A0 (sv) Neuroleptiska perhydro-1H-pyrido(1,2-a)pyraziner
YU104092A (sh) NEUROLEPTIČNI 2-SUPSTITUISANI PERHIDRO-1-H-PIRIDO(1,2-a) PIRAZINI
GB9022046D0 (en) New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
FI933652A (fi) Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler

Legal Events

Date Code Title Description
FD Application lapsed